(Q34547881)

English

Immunotherapy of sepsis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

Immunotherapy of sepsis. (English)

1 reference

Europe PubMed Central

2 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

T van der Poll

1

1 reference

Europe PubMed Central

2 August 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

2 August 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

2 August 2017

1

1 reference

Europe PubMed Central

2 August 2017

3

1 reference

Europe PubMed Central

2 August 2017

165-174

1 reference

Europe PubMed Central

2 August 2017

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokines and anticytokines in the pathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory therapies in sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical aspects: from systemic inflammation to 'immunoparalysis'.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials of mediator-directed therapy in sepsis: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroid controversy in sepsis and septic shock: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of late septic shock with supraphysiologic doses of hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-endotoxin therapeutic options for the treatment of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological therapy of sepsis: experimental therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Compartmentalized cytokine production within the human lung in unilateral pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Perioperative pattern of peritoneal interleukin 8, tumour necrosis factor-alpha, and granulocyte elastase release in human secondary peritonitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-10 impairs host defense in murine pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dysregulation of in vitro cytokine production by monocytes during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of Interleukin 6 and Transforming Growth Factor–β in the Induction of Depressed Splenocyte Responses Following Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin E2 down-regulation of T cell IL-2 production is independent of IL-10 during gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Monocyte deactivation in septic patients: restoration by IFN-gamma treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of granulocyte colony-stimulating factor in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombin III in animal models of sepsis and organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Toll-like receptors in the induction of the innate immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Superantigens and their potential role in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Superantigen antagonist peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic dissection of the molecular pathogenesis of severe infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900093-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(01)00093-7

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34547881&oldid=2042182785"